题名 | Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate |
作者 | |
通讯作者 | Li, Zhi-jie; Jiang, Yong; Wang, Ji-gang |
发表日期 | 2023-04-01
|
DOI | |
发表期刊 | |
ISSN | 1671-4083
|
EISSN | 1745-7254
|
摘要 | Liver, as an immune and detoxification organ, represents an important line of defense against bacteria and infection and a vulnerable organ that is easily injured during sepsis. Artesunate (ART) is an anti-malaria agent, that also exhibits broad pharmacological activities including anti-inflammatory, immune-regulation and liver protection. In this study, we investigated the cellular responses in liver to sepsis infection and ART hepatic-protective mechanisms against sepsis. Cecal ligation and puncture (CLP)-induced sepsis model was established in mice. The mice were administered ART (10 mg/kg, i.p.) at 4 h, and sacrificed at 12 h after the surgery. Liver samples were collected for preparing single-cell RNA transcriptome sequencing (scRNA-seq). The scRNA-seq analysis revealed that sepsis-induced a dramatic reduction of hepatic endothelial cells, especially the subtypes characterized with proliferation and differentiation. Macrophages were recruited during sepsis and released inflammatory cytokines (Tnf, Il1b, Il6), chemokines (Ccl6, Cd14), and transcription factor ( Nfkb1), resulting in liver inflammatory responses. Massive apoptosis of lymphocytes and abnormal recruitment of neutrophils caused immune dysfunction. ART treatment significantly improved the survival of CLP mice within 96 h, and partially relieved or reversed the above-mentioned pathological features, mitigating the impact of sepsis on liver injury, inflammation, and dysfunction. This study provides comprehensive fundamental proof for the liver protective efficacy of ART against sepsis infection, which would potentially contribute to its clinical translation for sepsis therapy. |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 通讯
|
资助项目 | Establishment of Sino-Austria "Belt and Road" Joint Laboratory on Traditional Chinese Medicine for Severe Infectious Diseases and Joint Research[2020YFE0205100]
; National Key Research and Development Program of China["2020YFA0908000","2022YFC2303600"]
; Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine[ZYYCXTD-C-202002]
; National Natural Science Foundation of China["82141001","82274182","82074098","82173914"]
; CACMS Innovation Fund["CI2021A05101","CI2021A05104"]
; Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences[CI2021B014]
; Science and Technology Foundation of Shenzhen[JCYJ20210324115800001]
; Fundamental Research Funds for the Central Public Welfare Research Institutes["ZZ14-YQ-050","ZZ14-YQ-051","ZZ14-YQ-052","ZZ14-FL-002","ZZ14-ND-010","ZZ15-ND-10"]
; Shenzhen Governmental Sustainable Development Fund[KCXFZ20201221173612034]
; Shenzhen Key Laboratory of Kidney Diseases[ZDSYS201504301616234]
; Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties[SZGSP001]
|
WOS研究方向 | Chemistry
; Pharmacology & Pharmacy
|
WOS类目 | Chemistry, Multidisciplinary
; Pharmacology & Pharmacy
|
WOS记录号 | WOS:000969020000001
|
出版者 | |
ESI学科分类 | PHARMACOLOGY & TOXICOLOGY
|
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:5
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/583130 |
专题 | 南方科技大学第一附属医院 |
作者单位 | 1.China Acad Chinese Med Sci, Artemisinin Res Ctr, Beijing 100700, Peoples R China 2.China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China 3.Southern Univ Sci & Technol, Shenzhen Peoples Hosp, Affiliated Hosp 1, Dept Nephrol,Shenzhen Key Lab Kidney Dis, Shenzhen 518020, Peoples R China 4.Southern Univ Sci & Technol, Shenzhen Peoples Hosp, Affiliated Hosp 1, Shenzhen Clin Res Ctr Geriatr, Shenzhen 518020, Peoples R China 5.Jiangxi Univ Chinese Med, Natl Pharmaceut Engn Ctr Solid Preparat Chinese He, Nanchang 330004, Peoples R China 6.China Acad Chinese Med Sci, Beijing 100700, Peoples R China 7.Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore 8.Stanford Univ, Sch Med, Adv Drug Delivery & Regenerat Biomat Lab, Stanford, CA 94304 USA 9.Stanford Univ, Sch Med, Cardiovasc Pharmacol Div Cardiovasc Inst, Stanford, CA 94304 USA 10.Southern Med Univ, Sch Basic Med Sci, Guangdong Prov Key Lab Prote, Guangzhou 510515, Peoples R China |
第一作者单位 | 南方科技大学第一附属医院 |
通讯作者单位 | 南方科技大学第一附属医院 |
推荐引用方式 GB/T 7714 |
He, Xue-ling,Chen, Jia-yun,Feng, Yu-lin,et al. Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate[J]. ACTA PHARMACOLOGICA SINICA,2023.
|
APA |
He, Xue-ling.,Chen, Jia-yun.,Feng, Yu-lin.,Song, Ping.,Wong, Yin Kwan.,...&Wang, Ji-gang.(2023).Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate.ACTA PHARMACOLOGICA SINICA.
|
MLA |
He, Xue-ling,et al."Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate".ACTA PHARMACOLOGICA SINICA (2023).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论